Global contract development and manufacturing organisation (CDMO) Recipharm, has announced the appointment of Joaquim Mascaro as Chief Financial Officer.

Joaquim has worked for a range of organisations in the pharma, biotech and healthcare industries, across the US, Asia and Latin America. His experience in building and developing strong teams will be essential in supporting the organisation through its next phase of growth.

Marc Funk, CEO Recipharm said: 'I am delighted to welcome Joaquim to the Recipharm team as we continue to drive our business forward. Joaquim's impressive credentials and expertise will be a real asset to the senior leadership team and to the business'.

Commenting on his appointment, Joaquim said: 'Recipharm's reputation and service offering in the industry is second to none. I am thrilled to be working for a leading top five CDMO on the quest for continuous growth'.

Contact:

Email: imogen.quail@ramarketingpr.com

Tel: +44 (0)191 222 1242

About Recipharm

Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden.

(C) 2023 Electronic News Publishing, source ENP Newswire